NLRP3 and gout: In rats with MSU-induced gouty arthritis, the nanoformulation inhibited the NLRP3 and NF-κB pathway, reduced the expression of pro-inflammatory cytokines in the inflamed rat joints, and ameliorated paw swelling and bone destruction more significantly than 10 alone [77].